Renal Insufficiency  >>  Halaven (eribulin mesylate)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Halaven (eribulin mesylate) / Eisai
NCT01418677: An Open-Label Study to Assess the Pharmacokinetics and Safety of HALAVEN in Subjects With Cancer Who Also Have Impaired Renal Function

Completed
1
19
US
E7389, Halaven
Eisai Inc.
Unspecified Adult Solid Tumor, Protocol Specific
07/14
05/15

Download Options